Acetylcholine, a neurotransmitter secreted by cholinergic neurons, is involved in signal
transduction related to memory and learning ability. Alzheimer's disease (AD), a progressive …

Alzheimer's disease, a major and increasing global health challenge, is an irreversible,
progressive form of dementia, associated with an ongoing decline of brain functioning. The …

Simple Summary This review was aimed at exploring the potentiality of drugging the
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …

Three prevalent neurodegenerative diseases, Parkinson's, Alzheimer's, and Huntington's
are in need of symptomatic relief of slowing disease progression or both. This chapter …

The triple transgenic Alzheimer's disease (3xTg-AD) strain is a common mouse model used
for studying the pathology and mechanism of Alzheimer's disease (AD). The 3xTg-AD strain …

Alzheimer's disease (AD) is a neurodegenerative disorder which accounts for 60–70% of the
50 million worldwide cases of dementia and is characterised by cognitive impairments …

Williams–Beuren syndrome (WBS) is a rare genetic multisystemic disorder characterized by
mild-to-moderate intellectual disability and hypersocial phenotype, while the most …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most
common cause of dementia in aging populations. Recently, the regulation of neurolipid …

The endocannabinoid system modulates learning, memory, and neuroinflammatory
processes, playing a key role in neurodegeneration, including Alzheimer's disease (AD) …

The endocannabinoid system (ECS) is composed of endogenous cannabinoids;
components involved in their synthesis, transport, and degradation; and an expansive …